Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
This study aimed to evaluate the efficacy of early antiviral treatment in preventing clinical deterioration in asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus 2 infected (COVID-19) patients in home isolation and to share our experiences with the ambulatory management...
محفوظ في:
المؤلف الرئيسي: | Sitasuwan T. |
---|---|
مؤلفون آخرون: | Mahidol University |
التنسيق: | مقال |
منشور في: |
2023
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://repository.li.mahidol.ac.th/handle/123456789/85377 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Mahidol University |
مواد مشابهة
-
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
بواسطة: Ricardo Águas, وآخرون
منشور في: (2022) -
Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19
بواسطة: Washirasaksiri C.
منشور في: (2023) -
Assessement of outcomes following implementation of antiviral treatment guidelines for covid-19 during the first wave in thailand
بواسطة: Narumol Sawanpanyalert, وآخرون
منشور في: (2022) -
Early diagnosis by antigen test kit and early treatment by antiviral therapy: An ambulatory management strategy during COVID-19 crisis in Thailand
بواسطة: Sayabovorn N.
منشور في: (2023) -
META-ANALYSIS OF RNA-SEQUENCING DATA FROM COVID-19 PATIENT WITH SEVERE SYMPTOMS ACQUIRING DEXAMETHASONE TREATMENT
بواسطة: Rizky Irfansyah, Adam